Prestige Consumer Healthcare Inc. (PBH) stock analysis
PBH · Prestige Consumer Healthcare Inc.
Latest recorded price: USD 48.00
Model-estimated fair value: USD 91.38. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic
At $48.00, PBH trades 47.5% below the model's base-case value of $91.38. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $63.72 in the conservative case and $122.11 in the optimistic case, with a valuation confidence score of 55/100. About 82% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2026 figures: revenue growth -1.2%, free cash flow margin 22.6%, ROIC 6.1%. The model flags 2 risk signals for this company (1 high severity).